ARTICLE | Clinical News
Xiidra lifitegrast regulatory update
July 18, 2016 7:00 AM UTC
FDA approved an NDA from Shire for Xiidra lifitegrast to treat signs and symptoms of dry eye disease in adults. Shire plans to launch the product this quarter. Xiidra is an eye drop formulation of a small molecule integrin beta(2) (LFA-1; MAC-1; CD18) antagonist. ...